Clinical trial
Optimization of the Primary Therapy for Patients With Hodgkin's Disease and…
NCT00188149 · University Hospital Carl Gustav Carus, Other · Unknown status
Key facts
| NCT number | NCT00188149 |
|---|---|
| Title | Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET |
| Official title | Optimization of the Primary Therapy for Patients With Hodgkin's Lymphoma and Evaluation of the Positron Emission Tomography (PET) as a Diagnostic Tool for Primary Staging and Assessment of the Effects of the Therapy |
| Lead sponsor | University Hospital Carl Gustav Carus, Other |
| Collaborators | Technische Universität Dresden |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hodgkin Disease |
| Intervention type | Drug, Procedure |
| Interventions | Combined chemotherapy (ABVD, BACOPP-D), Radiation therapy |
| Enrollment | 300 |
| Start date | May 1, 2000 |
| Completion | Dec 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Dec 29, 2005 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: